Nectar Lifesciences Limited

NSEI:NECLIFE 주식 보고서

시가총액: ₹7.0b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Nectar Lifesciences 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Amit Chadah

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기3.7yrs
CEO 소유권n/a
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간4yrs

최근 관리 업데이트

Recent updates

Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Feb 19
Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Dec 22
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Jun 16
Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jun 21
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jul 29
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Feb 25
Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Jan 21
Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Nov 02
Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Sep 07
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

Aug 09
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

Aug 09
The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Jul 13
What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

CEO

Amit Chadah (54 yo)

3.7yrs

테뉴어

Mr. Amit Chadah serves as the Chief Executive Officer of Nectar Lifesciences Limited since October 30, 2020. He was President of Business Development until October 30, 2020. He has joined the Nectar Lifesc...


리더십 팀

이름위치테뉴어보상소유권
Sanjiv Goyal
Chairman & MDno data₹20.49m44.35%
₹ 3.1b
Puneet Sud
Director of Operations & Wholetime Director1.8yrs₹3.52m데이터 없음
Amit Chadah
Chief Executive Officer3.7yrs데이터 없음데이터 없음
Sushil Kapoor
Chief Financial Officer1.6yrs데이터 없음데이터 없음
Neha Vaishnav
Company Secretary & Compliance Officer1.5yrs데이터 없음데이터 없음

1.8yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 관리: NECLIFE 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Sanjiv Goyal
Chairman & MDno data₹20.49m44.35%
₹ 3.1b
Puneet Sud
Director of Operations & Wholetime Director1.8yrs₹3.52m데이터 없음
Ajay Swaroop
Independent Non-Executive Director13.8yrs₹125.00k데이터 없음
Meena Verma
Nominee Director5.3yrs₹80.00k데이터 없음
Rupinder Tewari
Independent & Non-Executive Director5.3yrs₹155.00k데이터 없음
Kuldip Bhasin
Independent & Non-Executive Director2.8yrs₹155.00k데이터 없음
Indu Kaur
Independent & Non-Executive Director1.8yrs₹95.00k데이터 없음

4.0yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: NECLIFE 의 이사회경험(평균 재직 기간 4 년)으로 간주됩니다.